Literature DB >> 29916030

[The importance of molecular imaging (PET) in the diagnostics of dementia].

M Tscheuschler1, M Gebest2, F Jessen3,2, A Drzezga4,2.   

Abstract

Due to the expanding older population and increasing prevalence of dementia and currently lacking curative therapy but potentially conceivable availability of molecular-specific treatment to delay the progression of cognitive decline, the early diagnosis of cognitive deficits and their etiological differential diagnosis becomes increasingly more important. The advances in nuclear medicine diagnostics in the field of neurodegenerative diseases within the last few years have been substantial. In this article the relevance of these technologies in the diagnostic process of dementia is described.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid/Tau; Nuclear medicine diagnostics; Positron emission tomography; Progression delay

Mesh:

Year:  2018        PMID: 29916030     DOI: 10.1007/s00115-018-0533-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  30 in total

Review 1.  Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

Authors:  E Braak; K Griffing; K Arai; J Bohl; H Bratzke; H Braak
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 2.  Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.

Authors:  Stefan Teipel; Alexander Drzezga; Michel J Grothe; Henryk Barthel; Gaël Chételat; Norbert Schuff; Pawel Skudlarski; Enrica Cavedo; Giovanni B Frisoni; Wolfgang Hoffmann; Jochen René Thyrian; Chris Fox; Satoshi Minoshima; Osama Sabri; Andreas Fellgiebel
Journal:  Lancet Neurol       Date:  2015-08-26       Impact factor: 44.182

3.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

4.  SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.

Authors:  Satoshi Minoshima; Alexander E Drzezga; Henryk Barthel; Nicolaas Bohnen; Mehdi Djekidel; David H Lewis; Chester A Mathis; Jonathan McConathy; Agneta Nordberg; Osama Sabri; John P Seibyl; Margaret K Stokes; Koen Van Laere
Journal:  J Nucl Med       Date:  2016-08       Impact factor: 10.057

5.  The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

Authors:  M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; E Hoffman; A Alavi; P Som; L Sokoloff
Journal:  Circ Res       Date:  1979-01       Impact factor: 17.367

6.  Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.

Authors:  S Minoshima; N L Foster; A A Sima; K A Frey; R L Albin; D E Kuhl
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

7.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

8.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

9.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

10.  Variation in tau isoform expression in different brain regions and disease states.

Authors:  Elisa Majounie; William Cross; Victoria Newsway; Allissa Dillman; Jana Vandrovcova; Christopher M Morris; Michael A Nalls; Luigi Ferrucci; Michael J Owen; Michael C O'Donovan; Mark R Cookson; Andrew B Singleton; Rohan de Silva; Huw R Morris
Journal:  Neurobiol Aging       Date:  2013-02-19       Impact factor: 4.673

View more
  1 in total

1.  Nuclear medical imaging as part of dementia diagnostics in psychiatric day-care clinics and inpatient care settings.

Authors:  Jonathan Vogelgsang; Bernhard Kis; Katrin Radenbach; Claus Wolff-Menzler; Kiriaki Mavridou; Charles Timäus; Stephan Gyßer; Jens Wiltfang; Philipp Hessmann
Journal:  Aging Clin Exp Res       Date:  2019-07-08       Impact factor: 3.636

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.